Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Download App

Indian manufacturer, Kenyan firm clash over Sh1.3b pharmaceutical deal

Prescription drugs. [Courtesy]

An Indian pharmaceutical manufacturer is locked in a dispute worth more than Sh1.3 billion with a Kenyan firm and the Pharmacy and Poisons Board (PPB), in a row over a distribution agreement.

Prism Life Sciences Limited has accused the Board of siding with Galaxy Pharmaceutical Limited by permitting it to supply products from multiple companies, while at the same time freezing the distribution of Prism’s medicines

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902

Follow The Standard on Google News